|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating expenses: | |||||
| Research and development | |||||
| General and administrative | |||||
| Total operating expenses | |||||
| Operating loss | |||||
| Other income (expense): | |||||
| Interest income | |||||
| Other financing costs | |||||
| Change in fair value of warrants | |||||
| Total other income, net | |||||
| Income tax expense (benefit) | |||||
| Net loss | |||||
| Net loss per share | |||||
| Basic (dollars per share) | |||||
| Diluted (dollars per share) | |||||
| Weighted-average number of common shares used in computing net loss per share | |||||
| Basic | |||||
| Diluted | |||||
Loading...